Concepedia

Deqiao Sun

DS

5

Publications

129

Citations

5

H-Index

2017

Active since

Affiliations

University of Chinese Academy of Sciences(Current)

Shanghai Institute of Materia Medica

Chinese Academy of Sciences

ShanghaiTech University

Deqiao Sun is an author at University of Chinese Academy of Sciences specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2017–2021

5

Publications

5

Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes FXRhighPD-L1low NSCLC to Anti–PD-1 Immunotherapy

Wenjie You, Lijun Li, Deqiao Sun et al. · Cancer Immunology Research · 2019 · 45 citations

Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models

Peng Xia, Pengcong Hou, Yi Chen et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 32 citations · Full text

Discovery of pyrrolo[2,3-d]pyrimidine derivatives as potent Axl inhibitors: Design, synthesis and biological evaluation

Dandan Xu, Deqiao Sun, Wei Wang et al. · European Journal of Medicinal Chemistry · 2021 · 20 citations · Full text

, , +10

Discovery of 2,4-diarylaminopyrimidines bearing a resorcinol motif as novel ALK inhibitors to overcome the G1202R resistant mutation

Kaijun Geng, Zongjun Xia, Yinchun Ji et al. · European Journal of Medicinal Chemistry · 2017 · 16 citations · Full text

, , +12

SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors

Zongjun Xia, Yinchun Ji, Deqiao Sun et al. · Acta Pharmacologica Sinica · 2020 · 16 citations · Full text

, , +7

Rows per page

1–5 of 5